HBK Sorce Advisory LLC Acquires Shares of 7,983 Corteva, Inc. $CTVA

HBK Sorce Advisory LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,983 shares of the company’s stock, valued at approximately $628,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC boosted its position in shares of Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after purchasing an additional 261 shares in the last quarter. Clearstead Trust LLC bought a new position in shares of Corteva during the second quarter valued at $31,000. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at about $25,000. Westfuller Advisors LLC boosted its holdings in Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after purchasing an additional 387 shares during the last quarter. Finally, Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva in the 4th quarter worth $27,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on CTVA shares. BNP Paribas Exane boosted their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Oppenheimer upped their target price on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Bank of America raised their price target on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Citigroup lifted their price objective on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $91.70.

Corteva Stock Performance

Shares of CTVA opened at $75.73 on Tuesday. The stock has a fifty day moving average price of $81.78 and a 200-day moving average price of $80.09. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The firm has a market cap of $50.53 billion, a PE ratio of 50.15, a P/E/G ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the previous year, the firm posted $2.20 earnings per share. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.